Post by Clarivate for Life Sciences & Healthcare

What are biopharma leaders thinking about when it comes to AI? In our recent conversation with Fierce Biotech, Henry Levy shared several perspectives on how AI is reshaping decision-making across the life sciences industry. Some key discussion points: 👉AI is expanding the number of potential drug candidates and increasing the pace of development 👉The challenge is no longer access to data. It's understanding what the data means and acting on it quickly 👉AI alone isn't enough. Success depends on trusted, structured, decision-grade data 👉Human expertise remains critical for evaluating insights and making strategic decisions 👉Organizations may need to rethink existing processes, governance, and decision-making frameworks to fully realize the value of AI 👉The future belongs to organizations that combine AI-powered intelligence with scientific and commercial expertise Watch the full interview with Fierce Biotech: https://ow.ly/BWYe50ZiiFF Learn more about Clarivate's approach to trusted AI in life sciences: https://ow.ly/6GC250ZiiG9 #AI #Biotech #LifeSciences #DecisionIntelligence #Pharma #ArtificialIntelligence